Brokerages Set Ascendis Pharma A/S (NASDAQ:ASND) PT at $216.07
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) has earned a consensus rating of “Buy” from the fifteen ratings firms that are currently covering the company, Marketbeat reports. Fifteen equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued ratings on the stock in […]
Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) has earned a consensus rating of “Buy” from the fifteen ratings firms that are currently covering the company, Marketbeat reports. Fifteen equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued ratings on the stock in […]
